BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30226031)

  • 1. Degeneration of prosthesis after transcatheter aortic valve implantation.
    Costa G; Tamburino C; Barbanti M
    Minerva Cardioangiol; 2019 Feb; 67(1):57-63. PubMed ID: 30226031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in transcatheter aortic bioprosthesis durability.
    Petronio AS; Giannini C
    Expert Rev Cardiovasc Ther; 2019 Dec; 17(12):857-862. PubMed ID: 31847620
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
    Capodanno D; Petronio AS; Prendergast B; Eltchaninoff H; Vahanian A; Modine T; Lancellotti P; Sondergaard L; Ludman PF; Tamburino C; Piazza N; Hancock J; Mehilli J; Byrne RA; Baumbach A; Kappetein AP; Windecker S; Bax J; Haude M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):408-417. PubMed ID: 28874031
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural valve deterioration after transcatheter aortic valve implantation.
    Foroutan F; Guyatt GH; Otto CM; Siemieniuk RA; Schandelmaier S; Agoritsas T; Vandvik PO; Bhagra S; Bagur R
    Heart; 2017 Dec; 103(23):1899-1905. PubMed ID: 28684441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to Define Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves: Facts and Misconceptions.
    Capodanno D; Søndergaard L
    JACC Cardiovasc Interv; 2020 Jan; 13(2):257-260. PubMed ID: 31973798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
    Capodanno D; Petronio AS; Prendergast B; Eltchaninoff H; Vahanian A; Modine T; Lancellotti P; Sondergaard L; Ludman PF; Tamburino C; Piazza N; Hancock J; Mehilli J; Byrne RA; Baumbach A; Kappetein AP; Windecker S; Bax J; Haude M
    Eur Heart J; 2017 Dec; 38(45):3382-3390. PubMed ID: 29020344
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of structural valve deterioration and bioprosthetic valve failure utilizing the new European consensus definition in patients undergoing TAVI with first-generation devices: Outcomes beyond 5 years from a single center in Turkey.
    Şentürk B; Dursun H; Çöllüoğlu T; Özdamar H; Ekin T; Tanrıverdi Z; Kaya D
    Anatol J Cardiol; 2021 Aug; 25(8):579-587. PubMed ID: 34369886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second transcatheter aortic valve implantation for treatment of suboptimal function of previously implanted prosthesis: review of the literature.
    Witkowski A; Jastrzebski J; Dabrowski M; Chmielak Z
    J Interv Cardiol; 2014 Jun; 27(3):300-7. PubMed ID: 24731263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation.
    Salaun E; Clavel MA; Rodés-Cabau J; Pibarot P
    Heart; 2018 Aug; 104(16):1323-1332. PubMed ID: 29735584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISE.
    Indolfi C; Bartorelli AL; Berti S; Golino P; Esposito G; Musumeci G; Petronio S; Tamburino C; Tarantini G; Ussia G; Vassanelli C; Spaccarotella C; Violini R; Mercuro G; Romeo F
    J Cardiovasc Med (Hagerstown); 2018 May; 19(5):197-210. PubMed ID: 29578921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Transcatheter Aortic Valve Durability.
    Costa G; Criscione E; Todaro D; Tamburino C; Barbanti M
    Interv Cardiol; 2019 May; 14(2):62-69. PubMed ID: 31178931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far.
    Sawaya F; Jørgensen TH; Søndergaard L; De Backer O
    Front Cardiovasc Med; 2019; 6():145. PubMed ID: 31637246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition.
    Eltchaninoff H; Durand E; Avinée G; Tron C; Litzler PY; Bauer F; Dacher JN; Werhlin C; Bouhzam N; Bettinger N; Candolfi P; Cribier A
    EuroIntervention; 2018 Jun; 14(3):e264-e271. PubMed ID: 29599103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Vahanian A; Alfieri OR; Al-Attar N; Antunes MJ; Bax J; Cormier B; Cribier A; De Jaegere P; Fournial G; Kappetein AP; Kovac J; Ludgate S; Maisano F; Moat N; Mohr FW; Nataf P; Pierard L; Pomar JL; Schofer J; Tornos P; Tuzcu M; van Hout B; von Segesser LK; Walther T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):1-8. PubMed ID: 18502659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Vahanian A; Alfieri O; Al-Attar N; Antunes M; Bax J; Cormier B; Cribier A; De Jaegere P; Fournial G; Kappetein AP; Kovac J; Ludgate S; Maisano F; Moat N; Mohr F; Nataf P; Piérard L; Pomar JL; Schofer J; Tornos P; Tuzcu M; van Hout B; Von Segesser LK; Walther T; ; ;
    Eur Heart J; 2008 Jun; 29(11):1463-70. PubMed ID: 18474941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAVI and valve performance: update on definitions, durability, transcatheter heart valve failure modes and management.
    Eltchaninoff H; Durand E; Barbanti M; Abdel-Wahab M
    EuroIntervention; 2018 Aug; 14(AB):AB64-AB73. PubMed ID: 30158097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year echocardiographic follow-up after TAVI: structural and functional changes of a balloon-expandable prosthetic aortic valve.
    Muratori M; Fusini L; Tamborini G; Gripari P; Ghulam Ali S; Mapelli M; Fabbiocchi F; Trabattoni P; Roberto M; Agrifoglio M; Alamanni F; Bartorelli AL; Pepi M
    Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):389-397. PubMed ID: 28379513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late degeneration of transcatheter aortic valves: pathogenesis and management.
    Barbanti M; Tamburino C
    EuroIntervention; 2016 Sep; 12(Y):Y33-6. PubMed ID: 27640028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve durability: a contemporary clinical review.
    Montarello NJ; Willemen Y; Tirado-Conte G; Travieso A; Bieliauskas G; Sondergaard L; De Backer O
    Front Cardiovasc Med; 2023; 10():1195397. PubMed ID: 37229228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failing transcatheter aortic valve treated by transcatheter aortic valve in transcatheter aortic valve (TAV-in-TAV) implantation: valve safety versus valve durability.
    Vaquerizo B; Martucci G; Buithieu J; de Varennes B; Lachappelle K; Piazza N
    EuroIntervention; 2014 Dec; 10(8):1000. PubMed ID: 25540083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.